查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602190

經皮貼片市場：按產品類型、技術、應用、分銷管道和最終用戶分類 - 全球預測 2025-2030

Transdermal Patches Market by Product, Type, Technology, Application, Distribution Channel, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年經皮貼片市場估值為85.7億美元，預計到2024年將達到98.9億美元，複合年成長率為16.40%，預計到2030年將達到248.4億美元。

經皮貼片是一種黏性貼劑，可透過皮膚輸送藥物，確保藥物在較長時間內穩定且受控地釋放到血液中。它的非侵入性、改善的患者依從性以及繞過消化器官系統的能力使其對於吞嚥困難或需要特定藥物的患者來說是不可或缺的。治療範圍從疼痛管理和尼古丁戒斷到荷爾蒙補充療法和慢性病治療。最終用途主要包括醫療保健設施、診所和居家醫療環境。經皮貼劑市場的成長主要是由慢性病的增加、經皮給藥系統的採用增加以及貼片技術的進步所推動的。新的商機在於智慧技術的整合，例如用於劑量監測的感測器和針對特定患者需求的個人化醫療方法。公司可以從研發投資中受益，開發具有多種功能的貼片，例如不僅可以輸送藥物，還可以監測生命徵象的貼片。其局限性包括皮膚刺激問題、某些藥物的滲透性有限以及患者皮膚吸收的差異，這些都對療效提出了挑戰。此外，出於安全考慮，新經皮系統的監管核准可能會很嚴格，這可能會延遲產品上市。市場競爭非常激烈，主要企業都專注於產品組合擴張和地理影響力。創新機會存在於生物相容性材料的開發中，這些材料可以改善貼片黏附力並最大限度地減少皮膚反應，以及目前尚未廣泛使用的生技藥品的經皮給藥選擇。趨勢包括轉向混合系統，將經皮貼片和注射成分結合起來，以實現更全面的藥物傳遞方法。由於技術進步和消費者偏好的變化，市場的性質正在發生動態變化，持續的創新和適應對於經皮貼片配方產業的持續成長和競爭優勢至關重要。

主要市場統計
基準年[2023] 85.7億美元
預測年份 [2024] 98.9億美元
預測年份 [2030] 248.4億美元
複合年成長率（%） 16.40%

市場動態：快速發展的經皮貼片市場的關鍵市場洞察

供需的動態交互作用正在改變經皮貼片市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界各地用於治療慢性疾病的經皮貼片的興起
    • 人們越來越偏好控制釋放和非侵入性藥物輸送解決方案
    • 政府批准的經皮貼片數量增加
  • 市場限制因素
    • 與經皮貼片相關的高成本
  • 市場機會
    • 先進高效經皮給藥貼片研發進展
    • 經皮貼片配方和製造的新進展
  • 市場挑戰
    • 由於產品召回導致經皮製劑的局限性

波特的五力：駕馭經皮貼片市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解經皮貼片市場的外部影響

外部宏觀環境因素在塑造經皮貼片市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解經皮貼片市場的競爭狀況

對經皮貼片市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣式經皮貼片市場供應商績效評估

FPNV定位矩陣是評估經皮貼片市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球擴大使用經皮貼片來治療慢性疾病
      • 人們對受管制藥物釋放和非侵入性藥物輸送解決方案越來越感興趣
      • 政府核准的經皮貼片數量增加
    • 抑制因素
      • 與經皮貼片相關的高成本
    • 機會
      • 持續研發先進、高效率的經皮給藥貼劑
      • 經皮貼片配方和製造的新進展
    • 任務
      • 經皮藥物的限制和產品召回
  • 市場區隔分析
    • 產品名稱： 滲透力顯著的多層藥物貼片
    • 類型：尼古丁廣泛需求經皮貼片
    • 技術：利用化學增強劑提高經皮吸收貼片的功效
    • 應用：擴大經皮貼片在荷爾蒙療法的使用
    • 通路：經皮貼片在電商平台的普及
    • 最終使用者：醫院經皮貼片處方增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章經皮貼片市場：依產品

  • 矩陣
  • 多層藥物內黏劑
  • 水庫
  • 單層含藥黏劑

第7章經皮貼片市場：依類型

  • Buprenornhine經皮吸收貼片
  • 可樂定經皮吸收貼片
  • Fentanyl經皮吸收貼片
  • 尼古丁經皮吸收貼片
  • 奧昔布寧經皮吸收貼片

第8章經皮貼片市場：依技術分類

  • 化學強化劑
  • 目前的
  • 機械陣列
  • 熱消融

第9章經皮貼片市場：依應用分類

  • 荷爾蒙療法
  • 膀胱過動症
  • 緩解疼痛
  • 減少吸菸和戒菸支持

第10章經皮貼片市場：依通路分類

  • 離線
  • 線上

第11章經皮貼片市場：依最終用戶分類

  • 診所
  • 家庭護理設置
  • 醫院

第12章美洲經皮貼片市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太經皮貼片市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東和非洲經皮貼片市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • DifGen Pharmaceuticals 在美國製造地推出了第二款產品 Aveva 藥物輸送系統，這是一種Buprenornhine經皮系統。擴大我們的美國製造經皮貼片和舌下膜的製造和分銷產品組合。
    • 綠葉製藥在英國推出阿茲海默症新療法
    • Corsair Pharma 宣布提供 2,300 萬美元 B 系列資金籌措，以推進肺動脈高壓臨床試驗
    • Vaxess 融資 900 萬美元加速 mRNA 疫苗貼片的開發
    • Almirall 以 4500 萬歐元獲得西班牙阿茲海默症治療藥物的行銷權
    • Corium 與 Lotus Pharmaceuticals 簽署創新阿茲海默症治療藥物「ADLARITY」在多個亞洲市場的獨家授權合約
    • Dexmedetomidine經皮吸收貼片突然核准用於術後疼痛管理
    • LTS 透過收購 Sorel 的穿戴式注射設備業務完成聚合物藥物傳輸領域
    • BioNxt 帕金森氏症藥物rotigotine經皮吸收貼片獲得歐洲臨床試驗核准
    • Bioxt 簽署治療帕金森氏症的rotigotine經皮吸收貼片臨床試驗協議，並開始生產臨床樣品
    • LTS Roman主導投資專門從事無針分娩的公司
    • 收購 Tesa Labtec GmbH 是 AdhexPharma 發展的基石

公司名單

  • Novartis AG
  • Luye Pharma Group Ltd
  • Gedeon Richter Plc
  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • DifGen Pharmaceuticals LLC
  • Zydus Group
  • Bliss GVS Pharma Ltd.
  • Sparsha Pharma International Pvt Ltd
  • GlaxoSmithKline Plc
  • LAVIPHARM GROUP HOLDING SA
  • Purdue Pharma LP
  • Nitto Denko Corporation
  • UCB SA
  • Corsair Pharma, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Tesa SE by Beiersdorf AG
  • Medherant Limited
  • ALVOGEN
  • AdhexPharma SAS
  • Tapemark by LTS Lohmann Therapie-Systeme AG
  • Icure Pharmaceutical Inc.
  • ProSolus, Inc.
  • Corium, Inc.
  • Viatris Inc.
  • Boehringer Ingelheim International GmbH
  • Endo International plc
  • BioNxt Solutions Inc.
  • Bayer AG
  • Nutriband Inc
  • Teikoku Seiyaku Co., Ltd.
  • Perrigo Company plc
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
Product Code: MRR-FD3F12D540F6

The Transdermal Patches Market was valued at USD 8.57 billion in 2023, expected to reach USD 9.89 billion in 2024, and is projected to grow at a CAGR of 16.40%, to USD 24.84 billion by 2030.

Transdermal patches are adhesive patches that deliver medication through the skin, ensuring steady and controlled release into the bloodstream over time. They are essential due to their non-invasive nature, improved patient compliance, and ability to bypass the gastrointestinal system, which makes them suitable for patients with swallowing difficulties or specific medication requirements. Applications span from pain management and nicotine withdrawal to hormone replacement therapy and chronic disease treatment. The end-use scope primarily includes healthcare facilities, clinics, and home healthcare settings. Growth in the transdermal patch market is primarily driven by rising chronic disease prevalence, increasing adoption of transdermal drug delivery systems, and advancements in patch technology. Emerging opportunities lie in the integration of smart technologies like sensors for dosage monitoring and personalized medicine approaches targeting specific patient needs. Companies might benefit from investing in R&D for developing patches with multifunctional capabilities, such as patches that not only deliver medication but also monitor vital signs. Limitations include skin irritation issues, limited permeability to certain drugs, and variability in skin absorption among patients, which pose challenges to efficacy. Furthermore, regulatory approval for new transdermal systems is stringent due to safety concerns, potentially slowing down product launches. The market is highly competitive, with key players focusing on expanding portfolios and geographical presence. Innovation opportunities exist in biocompatible materials to improve patch adhesion and minimize skin reactions, and developing transdermal delivery options for biologics, which are currently underrepresented. Trends show a shift towards hybrid systems that combine transdermal patches with injectable components for a more comprehensive drug delivery method. The market's nature is dynamic, driven by technological advancements and evolving consumer preferences, making ongoing innovation and adaptation crucial for sustained growth and competitive advantage in the transdermal patch industry.

KEY MARKET STATISTICS
Base Year [2023] USD 8.57 billion
Estimated Year [2024] USD 9.89 billion
Forecast Year [2030] USD 24.84 billion
CAGR (%) 16.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transdermal Patches Market

The Transdermal Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased use of transdermal patches to treat chronic conditions worldwide
    • Rising preference for controlled drug release and non-invasive drug delivery solutions
    • Growing number of government approvals for transdermal patches
  • Market Restraints
    • High costs associated with transdermal patches
  • Market Opportunities
    • Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
    • Emerging advances in the formulation and manufacturing of transdermal patches
  • Market Challenges
    • Limitations associated with transdermal drugs along with product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Transdermal Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transdermal Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transdermal Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transdermal Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transdermal Patches Market

A detailed market share analysis in the Transdermal Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transdermal Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transdermal Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include Novartis AG, Luye Pharma Group Ltd, Gedeon Richter Plc, Johnson & Johnson Services, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., DifGen Pharmaceuticals LLC, Zydus Group, Bliss GVS Pharma Ltd., Sparsha Pharma International Pvt Ltd, GlaxoSmithKline Plc, LAVIPHARM GROUP HOLDING S.A., Purdue Pharma L.P., Nitto Denko Corporation, UCB S.A., Corsair Pharma, Inc., Amneal Pharmaceuticals, Inc., Tesa SE by Beiersdorf AG, Medherant Limited, ALVOGEN, AdhexPharma SAS, Tapemark by LTS Lohmann Therapie-Systeme AG, Icure Pharmaceutical Inc., ProSolus, Inc., Corium, Inc., Viatris Inc., Boehringer Ingelheim International GmbH, Endo International plc, BioNxt Solutions Inc., Bayer AG, Nutriband Inc, Teikoku Seiyaku Co., Ltd., Perrigo Company plc, and Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc..

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Matrix, Multi-layer Drug-in-Adhesive, Reservoir, and Single-layer Drug-in-Adhesive.
  • Based on Type, market is studied across Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, and Oxybutynin Transdermal Patch.
  • Based on Technology, market is studied across Chemical Enhancers, Electric Current, Mechanical Arrays, and Thermal Ablation.
  • Based on Application, market is studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction & Cessation Aid.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End Users, market is studied across Clinics, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
      • 5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
      • 5.1.1.3. Growing number of government approvals for transdermal patches
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with transdermal patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
      • 5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with transdermal drugs along with product recalls
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
    • 5.2.2. Type: Extensive requirement for nicotine transdermal patches
    • 5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
    • 5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
    • 5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
    • 5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transdermal Patches Market, by Product

  • 6.1. Introduction
  • 6.2. Matrix
  • 6.3. Multi-layer Drug-in-Adhesive
  • 6.4. Reservoir
  • 6.5. Single-layer Drug-in-Adhesive

7. Transdermal Patches Market, by Type

  • 7.1. Introduction
  • 7.2. Buprenorphine Transdermal Patch
  • 7.3. Clonidine Transdermal Patch
  • 7.4. Fentanyl Transdermal Patch
  • 7.5. Nicotine Transdermal Patch
  • 7.6. Oxybutynin Transdermal Patch

8. Transdermal Patches Market, by Technology

  • 8.1. Introduction
  • 8.2. Chemical Enhancers
  • 8.3. Electric Current
  • 8.4. Mechanical Arrays
  • 8.5. Thermal Ablation

9. Transdermal Patches Market, by Application

  • 9.1. Introduction
  • 9.2. Hormonal Therapy
  • 9.3. Overactive Bladder
  • 9.4. Pain Relief
  • 9.5. Smoking Reduction & Cessation Aid

10. Transdermal Patches Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Transdermal Patches Market, by End Users

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Home Care Settings
  • 11.4. Hospitals

12. Americas Transdermal Patches Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Transdermal Patches Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Transdermal Patches Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
    • 15.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
    • 15.3.3. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
    • 15.3.4. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
    • 15.3.5. Almirall Acquires Rights To Distribute Alzheimer's Treatment In Spain For An Initial EUR 45 Million
    • 15.3.6. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
    • 15.3.7. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
    • 15.3.8. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
    • 15.3.9. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.10. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.11. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
    • 15.3.12. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma's Growth Path

Companies Mentioned

  • 1. Novartis AG
  • 2. Luye Pharma Group Ltd
  • 3. Gedeon Richter Plc
  • 4. Johnson & Johnson Services, Inc.
  • 5. AbbVie Inc.
  • 6. Teva Pharmaceutical Industries Ltd.
  • 7. DifGen Pharmaceuticals LLC
  • 8. Zydus Group
  • 9. Bliss GVS Pharma Ltd.
  • 10. Sparsha Pharma International Pvt Ltd
  • 11. GlaxoSmithKline Plc
  • 12. LAVIPHARM GROUP HOLDING S.A.
  • 13. Purdue Pharma L.P.
  • 14. Nitto Denko Corporation
  • 15. UCB S.A.
  • 16. Corsair Pharma, Inc.
  • 17. Amneal Pharmaceuticals, Inc.
  • 18. Tesa SE by Beiersdorf AG
  • 19. Medherant Limited
  • 20. ALVOGEN
  • 21. AdhexPharma SAS
  • 22. Tapemark by LTS Lohmann Therapie-Systeme AG
  • 23. Icure Pharmaceutical Inc.
  • 24. ProSolus, Inc.
  • 25. Corium, Inc.
  • 26. Viatris Inc.
  • 27. Boehringer Ingelheim International GmbH
  • 28. Endo International plc
  • 29. BioNxt Solutions Inc.
  • 30. Bayer AG
  • 31. Nutriband Inc
  • 32. Teikoku Seiyaku Co., Ltd.
  • 33. Perrigo Company plc
  • 34. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.

LIST OF FIGURES

  • FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 285. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023